Most Recent
Dow loses latest spat with Nufarm over patent for low vapour drift herbicide
Intellectual Property 2023-07-04 3:03 pm By Cindy Cameronne

The successor of Dow Agrosciences has lost its latest bid to register a patent that is aimed at limiting the worldwide problem of herbicide vapour […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Seven tries to resurrect ‘7Now’ mark in IP stoush with 7-Eleven
Appeals 2023-06-26 11:41 pm By Cat Fredenburgh

Seven Network has appealed a ruling that revoked its 7NOW trade mark for non-use in a victory for convenience chain 7-Eleven as it seeks to […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Seven loses stoush with 7-Eleven over ‘7NOW’ trade mark
Intellectual Property 2023-06-08 11:38 pm By Gareth Baker

Seven Network has lost its effort to stop convenience chain 7-Eleven from using a contested logo even though Seven had registered the trade mark first, […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

King & Wood Mallesons drops Ye in case against College Dropout Burgers
Intellectual Property 2023-02-20 11:29 pm By Christine Caulfield

Big Six firm King & Wood Mallesons has withdrawn its representation of US rapper Ye in his case against a small Melbourne restaurant after the […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Sportsbet wins anti-suit injunction against US case by sportsbet.com owner
Gaming 2023-01-12 11:49 am By Sam Matthews

Sportsbet has won an injunction preventing the owner of the sportsbet.com domain from prosecuting an action in the US, which a judge said sought to […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Drug companies drop bid for ACCC approval of Revlimid patent settlement
Competition & Consumer Protection 2022-07-29 11:44 am By Cat Fredenburgh

Bristol-Myers Squibb unit Celgene and two generic drug makers have withdrawn an application for ACCC approval of a patent settlement that would have allowed for […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Dow’s vapor-drift fighting herbicide patent not new, IP Australia finds in win for Nufarm 
Intellectual Property 2022-07-07 4:41 pm By Christine Caulfield

Nufarm Australia has successfully challenged a herbicide patent application by Dow Agrosciences’ successor on the grounds that the invention – aimed at limiting the worldwide […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Full Court shoots down Boehringer opposition to Merck Sharp & Dohme’s parasite patent
Intellectual Property 2022-05-19 3:38 pm By Cat Fredenburgh

The Full Federal Court has rejected German drug maker Boehringer Ingelheim’s appeal of ruling that shot down its opposition to Merck Sharp & Dohme’s patent […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Biotechs Gen-Probe, Beckman Coulter settle spat over ‘Access’ trade marks
Intellectual Property 2022-03-30 10:01 pm By Miklos Bolza

The Federal Court has signed off on a settlement between two US biotech companies that ends a dispute over the companies’ ‘Access’ trade marks in […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

ACCC says agreement to settle Revlimid patent suit could violate cartel laws
Intellectual Property 2022-03-23 2:53 pm By Cat Fredenburgh

The ACCC has refused to authorise a patent settlement and license agreement between Bristol-Myers Squibb unit Celgene and two generic drug makers who sued to […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.